Avidity biosciences announces appointment of john b. moriarty, jr. as chief legal officer

San diego , aug. 5, 2024 /prnewswire/ -- avidity biosciences, inc. (nasdaq: rna), a biopharmaceutical company committed to delivering a new class of rna therapeutics called antibody oligonucleotide conjugates (aocs™), today announced the appointment of john b. moriarty, jr., j.d.

RNA Ratings Summary

RNA Quant Ranking